Summary & Overview
HCPCS G9413: CIED Infection Requiring Device Removal or Surgical Revision
HCPCS Level II code G9413 denotes a patient not admitted within 180 days who is status post cardiac implantable electronic device (CIED) implantation, replacement, or revision complicated by infection requiring device removal or surgical revision. The code captures a specific clinical scenario tied to device-related infection management and surgical intervention, relevant to hospitals, surgical centers, and payers managing device complications nationwide.
Key payers covered in this analysis include Medicare, Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. Readers will find a concise national overview of the code's clinical context, how it maps to surgical service lines and typical sites of care, and the policy and billing considerations that affect coverage and claims processing. The publication highlights common modifiers associated with surgical services, notes gaps where input data is unavailable, and outlines areas where institutions and payers often need clear documentation to support claims.
This briefing is intended to inform coding professionals, revenue cycle managers, and policy analysts about the clinical definition and billing context of G9413, typical care settings, and the payer landscape relevant to device infection removals and surgical revisions.
Billing Code Overview
HCPCS Level II code G9413 describes a patient who was not admitted within 180 days and is status post cardiac implantable electronic device (CIED) implantation, replacement, or revision with an infection requiring device removal or surgical revision.
-
Service type: Surgical management of infected CIED, including device removal and/or surgical revision
-
Typical site of service: Inpatient or outpatient hospital surgical setting, or ambulatory surgical center depending on clinical status and need for admission
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a previously implanted cardiac implantable electronic device (CIED)—such as a pacemaker or implantable cardioverter-defibrillator (ICD)—presents to an outpatient electrophysiology clinic with localized pocket erythema, drainage, and systemic signs of infection (fever, elevated white blood cell count). Blood cultures are positive for Staphylococcus aureus. The patient is not admitted within the prior 180 days and requires device removal or surgical revision because of device-related infection. The typical clinical workflow includes outpatient evaluation by electrophysiology or cardiology, diagnostic testing (blood cultures, device pocket ultrasound or echocardiography if endocarditis suspected), antimicrobial therapy initiation, scheduling of device extraction or revision in an ambulatory surgery center or hospital outpatient department, and coordination for reimplantation planning once infection is controlled. Procedural consent, intraoperative cultures, and documentation of indication for extraction due to infection are included in the medical record. Post-procedure follow-up includes wound checks, continued antimicrobial therapy guided by cultures, and planning for reimplantation at a contralateral site when appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required for device removal or revision due to extensive adhesions, infection-related debridement, or prolonged surgical time. |